For the first time in Medicare's history, people with Part D prescription drug coverage have a guaranteed ceiling on what they can spend out of pocket on covered medications in a single year. In 2026, that cap is $2,000 — a landmark change that took effect January 1 and was made possible by the Inflation Reduction Act signed in 2022. This single policy shift has fundamentally changed how beneficiaries should evaluate Part D plans, because the catastrophic spending phase that used to expose people to unlimited costs no longer exists. If you take expensive specialty drugs for conditions like cancer, rheumatoid arthritis, or multiple sclerosis, this cap may save you thousands of dollars compared to what you paid just two years ago.
The $2,000 cap applies to what you pay in deductibles, copays, and coinsurance for drugs covered under your plan's formulary. It does not apply to your monthly premium, and it does not cover drugs that are not on your plan's formulary. This distinction matters enormously when comparing plans. A plan with a $0 monthly premium might have a formulary that excludes one of your critical medications, forcing you to pay full price — which would not count toward your cap. That's why the first step in evaluating any Part D plan is entering your exact list of medications into Medicare's Plan Finder tool, available at Medicare.gov, before looking at premiums or star ratings.
In 2026, the standard Part D benefit structure includes a deductible of up to $590 — though many plans waive this deductible for preferred generic drugs. After the deductible, you pay a share of drug costs (typically 25% coinsurance) until you hit the $2,000 out-of-pocket maximum. There is no longer a coverage gap, or "donut hole," which was phased out under the Inflation Reduction Act. This simplification is genuinely good news: the three-phase structure that confused beneficiaries for two decades has been replaced with a straightforward two-phase model — initial coverage, then catastrophic protection once you hit $2,000.
Another major 2026 feature is the Medicare Prescription Payment Plan, sometimes called the smoothing program. This optional program allows beneficiaries to spread their out-of-pocket drug costs across monthly installments throughout the year rather than paying large lump sums at the pharmacy counter in January or February when many people fill 90-day supplies. If you take a specialty drug that costs $800 out of pocket per fill, this program can prevent a financial shock early in the year. You must opt in through your Part D plan — it is not automatic — and enrollment is available at any time during the year.
When evaluating which Part D plan is best for you in 2026, there are five variables that matter most: monthly premium, annual deductible, your specific drugs' tier placement on the formulary, the pharmacy network (including whether your preferred pharmacy is preferred or standard), and the plan's CMS star rating. Star ratings run from 1 to 5 and reflect member satisfaction, drug safety measures, and customer service quality. Plans rated 4 stars or higher are generally considered strong performers. A 5-star plan carries a special enrollment privilege: you can switch into a 5-star plan at any time during the year, outside of the standard Annual Enrollment Period, using a Special Enrollment Period. This is a meaningful option if you're currently in a poorly performing plan.
Standalone Prescription Drug Plans (PDPs) are the Part D option for people in Original Medicare — traditional Medicare Parts A and B. In 2026, there are dozens of PDP options available nationally, offered by insurers including Humana, UnitedHealthcare (AARP), Cigna (Evernorth), Wellcare, and others. Premiums for standalone PDPs range from under $10 per month for basic plans in some regions to over $100 per month for enhanced plans with richer benefits. The lowest-premium plan is rarely the best value unless your drug costs are minimal. An enhanced plan with a $45 monthly premium but $0 copays on your Tier 1 and Tier 2 drugs may cost you far less annually than a $12-per-month plan with a $590 deductible and 25% coinsurance on those same drugs.
If you are enrolled in a Medicare Advantage plan, your prescription drug coverage typically comes bundled through a Medicare Advantage Prescription Drug plan (MA-PD). These plans may offer lower drug cost-sharing than standalone PDPs, but the tradeoff is that you're also subject to the Advantage plan's network restrictions for medical care. The $2,000 out-of-pocket cap applies to Part D drug costs in MA-PD plans as well, but it is separate from the plan's medical out-of-pocket maximum, which can be as high as $9,350 for in-network services in 2026. Understanding that these are two distinct caps — one for drugs, one for medical care — is essential when comparing total cost exposure.
Low-income beneficiaries should know that the Extra Help program (also called the Low-Income Subsidy, or LIS) continues in 2026 with updated thresholds. Full Extra Help is available to individuals with incomes up to 135% of the federal poverty level (roughly $20,780 for a single person in 2026) and limited assets. Full Extra Help recipients pay no more than $4.50 for generic drugs and $11.20 for brand-name drugs per prescription in 2026, with no deductible and no premium for benchmark plans. Partial Extra Help is available up to 150% of the federal poverty level. If you think you might qualify, apply through the Social Security Administration at ssa.gov or call 1-800-772-1213. Many people who qualify never apply.
The Annual Enrollment Period — October 15 through December 7 each year — is when most beneficiaries can switch Part D plans, with changes taking effect January 1. If you missed the 2025 AEP and are now in a plan that isn't serving you well, the Open Enrollment Period (January 1 through March 31) allows Medicare Advantage enrollees to switch plans or return to Original Medicare and add a standalone PDP. Standalone PDP enrollees do not have this option during OEP — they must wait for AEP unless they qualify for a Special Enrollment Period due to a qualifying life event such as moving, losing other drug coverage, or qualifying for Extra Help.
One practical step that many beneficiaries skip: call your plan's member services line each fall and ask them to run a cost comparison for your specific drugs under your current plan versus alternatives. Plans are required to provide this information. You can also use the State Health Insurance Assistance Program (SHIP) in your state — a free, unbiased counseling service staffed by trained volunteers — to get one-on-one help comparing plans. Find your local SHIP counselor at shiphelp.org or by calling 1-800-MEDICARE. These counselors do not sell insurance and have no financial stake in which plan you choose, making them one of the most trustworthy resources available to Medicare beneficiaries navigating an increasingly complex landscape.